Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
about
HIV and tuberculosis--science and implementation to turn the tide and reduce deathsCentral nervous system tuberculosisNine- to Twelve-Month Anti-Tuberculosis Treatment Is Associated with a Lower Recurrence Rate than 6-9-Month Treatment in Human Immunodeficiency Virus-Infected Patients: A Retrospective Population-Based Cohort Study in TaiwanHIV and Tuberculosis: a Deadly Human SyndemicTuberculosis patients' reasons for, and suggestions to address non-uptake of HIV testing: a cross-sectional study in the Free State Province, South Africa.The risk and timing of tuberculosis diagnosed in smear-negative TB suspects: a 12 month cohort study in Harare, Zimbabwe.TB-IRIS: Proteomic analysis of in vitro PBMC responses to Mycobacterium tuberculosis and response modulation by dexamethasoneAntiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational studyAssessing tuberculosis case fatality ratio: a meta-analysis.Evaluation of the rapid scale-up of collaborative TB/HIV activities in TB facilities in Rwanda, 2005-2009.Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township.AtriplaR/anti-TB combination in TB/HIV patients. Drug in focusPrevalence of national treatment algorithm defined smear positive pulmonary tuberculosis in HIV positive patients in Brazzaville, Republic of CongoOpportunities and barriers for implementation of integrated TB and HIV care in lower level health units: experiences from a rural western Ugandan district.Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006-2013).Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfectionGlobal epidemiology of tuberculosis.Access to tuberculosis services for individuals with disability in rural Malawi, a qualitative study.Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis.WHO recommended collaborative TB/HIV activities: evaluation of implementation and performance in a rural district hospital in CameroonTB/HIV integration at primary care level: A quantitative assessment at 3 clinics in Johannesburg, South Africa.Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe.Timing and uptake of ART during treatment for active tuberculosis in HIV co-infected adults in MalawiMortality among tuberculosis patients under DOTS programme: a historical cohort study.Research priorities in the field of HIV and AIDS in Iran.Unravelling the Gordian knot: diagnostic dilemma in an HIV-positive patient with neurological involvement.Antiretroviral therapy initiation during tuberculosis treatment and HIV-RNA and CD4 T-lymphocyte responses.Human immunodeficiency virus-associated tuberculosis: update on prevention and treatmentCharacteristics of adults and children diagnosed with tuberculosis in Lilongwe, Malawi: findings from an integrated HIV/TB clinicStrategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settingsTuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.Impact of WHO 2010 Guidelines on Antiretroviral Therapy Initiation among Patients with HIV-Associated Tuberculosis in Clinics with and without Onsite HIV Services in the Democratic Republic of CongoReducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.Predictors of mortality in a cohort of tuberculosis/HIV co-infected patients in Southwest Ethiopia.Management of individuals requiring antiretroviral therapy and TB treatment.HLA-B*57 Allele Is Associated with Concomitant Anti-tuberculosis and Antiretroviral Drugs Induced Liver Toxicity in Ethiopians.Poor prognosis of HIV-associated tuberculous meningitis regardless of the timing of antiretroviral therapy.
P2860
Q26824501-1B841546-792A-47A8-897F-B69127C95A5EQ28237650-E85E4396-ED7A-43CE-A94B-A9774F332600Q28551297-193F6042-516F-4325-87A0-6710471F1A7CQ30052157-57DA55E8-D325-4122-8C6D-F460C15B3537Q31012681-6FDB8FCE-F3CA-453A-87D0-26D28BC725CBQ33646721-61D0B783-2866-4F92-BC81-452E67CB7B3CQ33732480-0E29AEA3-7015-4413-A0DA-DB8D8D400B5AQ33795967-F04CFB8B-02AB-476C-8EB6-9456DC0331B0Q33909586-01B64795-F69F-44D8-AB2D-ECAD6C3E5DF0Q33954598-26825CD1-B691-496E-8110-EFC1BC656504Q33957232-FC4C3DB9-50DD-47C4-A751-9431BF60728CQ34034880-FCCC00E2-E321-4461-B6F1-5B842D663492Q34083071-697A924F-721A-4C4E-AFA5-C56728865E94Q34203557-FD4470B3-C8EF-49E6-AC3F-C2D0CC5E4B7BQ34643122-9526299B-009F-4AB7-8886-DDC0194BCAA5Q34704432-1EA0D261-1BF8-4B73-94A9-D18F1D31E620Q34787863-B4DE1A13-C9E8-41DE-85E1-E001FD99BECFQ34914625-0CF7B691-3C47-4311-AA69-ECC4BCBF29DEQ35045088-F4DE2956-7C53-4CB2-AF62-CEFC16919405Q35242918-AD173D01-1DFA-4484-B9A7-D3581868B846Q35336481-E16AE9D4-588E-4CB1-9058-9CDD00CCA996Q35619527-9738BDB1-3E16-4876-A150-5FCFCFD3FE37Q35702713-64B6B132-BDEF-41E9-B3F3-6F44FA674137Q35738013-FBAE32FC-B1D7-4B73-B61C-A23FCFAAF3A3Q35989599-8206A549-7EAD-4DF8-81FB-3391EC1C6F10Q36113498-D8132249-2F4D-4E02-805D-0A20AD61AD23Q36789810-590AA8C4-44B4-4E83-BAD3-ABB39DE37348Q36818168-4C4E8B54-C576-4072-9668-FEEF7B5DCE17Q37056172-B83E95A4-4A7F-4339-A4E4-3735C6EC4408Q37103666-751FC4C1-F546-4ED1-B9ED-F48A7C4BA856Q37158037-786096D0-4C7B-47CF-967E-865E70A1538AQ37168581-A125A8E6-3E42-4562-90BF-77B303DE8EEDQ37168588-736D5E9F-F337-4F18-93BF-6A6AFCC309CAQ37195317-97F08DED-A881-4092-AE43-B72FC1947B10Q37285167-6F2015FA-0534-4DCE-BB69-126D8404DF82Q37472441-69FF9744-8966-4CFA-A97B-963D3F699236Q37666456-1BD52A33-94C0-49C5-A4E9-49B4575F1A0BQ37667333-27A520EF-7C5B-4457-BA98-853B8E3822CFQ42735979-CBDF3E22-577A-4CA3-8469-BE6F0AC307A9
P2860
Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Providing HIV care for co-infe ...... ctive from sub-Saharan Africa.
@en
Providing HIV care for co-infe ...... ctive from sub-Saharan Africa.
@nl
type
label
Providing HIV care for co-infe ...... ctive from sub-Saharan Africa.
@en
Providing HIV care for co-infe ...... ctive from sub-Saharan Africa.
@nl
prefLabel
Providing HIV care for co-infe ...... ctive from sub-Saharan Africa.
@en
Providing HIV care for co-infe ...... ctive from sub-Saharan Africa.
@nl
P2093
P921
P1476
Providing HIV care for co-infe ...... ective from sub-Saharan Africa
@en
P2093
P577
2009-01-01T00:00:00Z